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Edited by Irmgard SinningAbstract We exploit the biochemical and sequence similarity
between Staphylococcus aureus Sav1866 and P-glycoprotein to
develop a homology model of P-glycoprotein representing an
ATP-bound state, which captures the major features of the
low-resolution EM structure and is consistent with cysteine
mutagenesis studies. Using insights from the MalK crystal struc-
tures and BtuCD simulations, we model two nucleotide-free con-
formations. Conformational changes are characterized by
pincering rigid-body rotations of the nucleotide-binding domains,
inducing transmembrane domain reorganizations which corre-
spond to the two lowest frequency normal modes of the protein.
These conformations (see supplementary material) may charac-
terize some of the major steps in the nucleotide catalytic cycle.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The ATP binding cassette (ABC) multi-drug transporter P-
glycoprotein (P-gp) prevents the cellular uptake of toxins by
actively transporting a wide range of compounds out of the cell
using the energy derived from ATP hydrolysis [1,2]. P-gp sub-
strates include chemotherapeutic drugs, antibiotics, steroid
hormones, immunosuppressants and HIV protease inhibitors
[3–5]. Continuous administration of therapeutic drugs can lead
to the overexpression of P-gp, resulting in multi-drug resis-
tance [6], which presents a major obstacle in the successful
treatment of cancer and HIV [3,7].
P-gp consists of a single polypeptide, 1280 residues in length,
organized into two homologous, pseudo-symmetrical domains
joined by a 60 residue linker. Each domain contains a trans-
membrane domain (TMD) of six helices, followed by a nucle-
otide-binding domain (NBD). The TMD and NBD areAbbreviations: P-gp, P-glycoprotein; NBD, nucleotide-binding do-
main; TMD, transmembrane domain; ICL, intracellular loop; EM,
electron microscopy; Sav1866, Staphylococcus aureus ABC transporter
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doi:10.1016/j.febslet.2007.07.069coupled by a series of intracellular loops (ICL) that extend into
the NBDs.
The two crucial factors that determine the quality of a
homology model are the accuracy and extent of the sequence
alignment between the protein of interest and the template
protein, and the quality of the crystal structure used as the
modelling template. While there are many ways to improve
the accuracy of the sequence alignment, such as structural pre-
dictions and multiple alignments, for the majority of trans-
membrane proteins the choice of template structures is a
critical limitation. The withdrawal of the MsbA crystal struc-
tures [8], on which all previous P-gp homology models were
based, has been a major setback to the ﬁeld, requiring a rein-
terpretation of many key pieces of experimental data [9]. The
organization and pseudo-symmetrical arrangement of TM
helices in the 8 A˚ electron microscopy (EM) structure [10] cor-
relates to the TMD symmetry of Sav1866, while the overall
dimensions of the two transporters also correspond. The recent
crystal structure of the prokaryotic homologue Sav1866 pro-
vides a new opportunity for comparative modelling [11]. Re-
cent biochemical evidence demonstrates P-gp possesses the
same domain inter-linking motif as Sav1866, where P-gp
ICL4 interacts with residues in NBD1 [12], strengthening the
argument for Sav1866 as a suitable template structure on
which to model P-gp.2. Materials and methods
2.1. Developing a homology model of P-gp in the closed state
We used an initial PSI-BLAST search [13] to identify possible tem-
plate structures for homology modelling. At the time of modelling, the
only suitable complete template structure isolated was the ADP-bound
S. aureus Sav1866 (2HYD.pdb) [11]. Although Sav1866 was crystal-
lized in the presence of ADP, the tightly coupled NBD conformation
and outwards-facing conﬁguration of the TMDs probably corresponds
to the ATP-bound state [11]. This shift in the conformational equilib-
rium to the ATP-bound state is thought to be an artefact arising from
the use of detergents in the crystallization process [11]. The Sav1866
conformation allowed us to develop a homology model of P-gp in
the ATP-bound conformation, referred to as the closed state P-gp.
We aligned two copies of Sav1866 with the human P-gp sequence
(NCBI AAA59575) and several other P-glycoproteins using ClustalW
[14]. Secondary structure predictions [15] for P-gp matched the
Sav1866 structure well. The sequence identity of the ﬁnal alignment
(Fig. S1) varies markedly for each domain. NBD1 and 2 have sequence
identities of 48.4% and 44.6%, respectively (sequence similarity is
80.4% and 77.8%); while TMD1 and 2 have sequence identities of
15.8% and 12.9%. respectively. When sequence similarity is considered,
this rises to 56% for TMD1 and 52.8% for TMD2.
Each P-gp half-transporter was modelled separately using Swiss-
Model [16]. Additional loop regions of P-gp were reconstructed fromblished by Elsevier B.V. All rights reserved.
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transporter models were dimerized to reproduce the Sav1866 subunit
interface, reﬁned to remove steric clashes and energy minimized [17].
To examine matching between the hydrophobic residues in the mem-
brane-spanning segments and the bilayer interior, the models were in-
serted into a pre-equilibrated palmitoyloleonyl-phosphatidyl-
ethanolamine (POPE) bilayers using the method described by Kandt
et al. [18]. Additional MD simulations were not performed, as short
timescale simulations have been shown to increase the backbone disor-
der of homology models [19].
The backbone root-mean-square deviation (RMSD) between
Sav1866 and the P-gp model was 0.30 A˚. Due to the lack of a template
structure, the RMSD could not be calculated for the 16 residue TM1–
TM2 insertion, which was modelled solely from secondary structure
predictions [15] and loop databases [17]. The quality of the entire P-
gp model (Fig. 1) was assessed on local factors such as packing quality,
backbone conformation, bond lengths and side chain planarity. The
primary assessment method, WHATIF [20], showed the P-gp model
was of comparable quality to Sav1866. However, WHATIF [20] (Table
S1) and PROCHECK [21] quality indicators performed poorly on all
the full ABC transporters crystallized to date (Table S1) with the
exception of the putative metal chelator, 2NQ2 [22]. Although widely
used for membrane proteins, these quality indicators were originally
developed for globular proteins, which may account for the poor per-
formance of the ABC transporter structures. This question needs fur-
ther investigation to be adequately addressed. Analysis of the
Ramachandran plot in SPDBV [17] showed 99% of all P-gp residues
fell within favorable regions, increasing our conﬁdence in the backbone
geometry.
The overall RMSD between the modelled P-gp NBDs and the ATP-
bound MalK structure (1Q12.pdb) was 1.27 A˚, while the backbone
RMSD of the Walker A/nucleotide/signature loop motifs was
<0.1 A˚, indicating the modelled P-gp, like the ADP- and AMP-PNP-
bound Sav1866 structures [11,23], exhibits a closed state, ATP-bound
conformation. The distance between Walker A cysteine residues is
33.7 A˚, correlating with FRET estimates predicting a separation of
30 A˚ throughout the catalytic cycle [24]. The P-gp model exhibits
the Sav1866 TMD outwards-facing conformation and domain inter-
linking pattern, where the ﬁrst two helices of one TMD associate with
the last four helices of the other TMD to give diverging TM ‘‘wings’’
[11] (Fig. 1).Fig. 1. (a) Front and (b) side views of the nucleotide-bound (cyan)
closed state P-gp homology model. (b) Side view shows a wing-like
TMD orientation. TMD1&NBD1 are silver, TMD2&NBD2 are dark
grey. ICL1&4 are blue, ICL2&5 are red, ICL3&6 are orange.2.2. Creating P-gp homology models that may represent two nucleotide-
free states
Experiments [25] and simulations on MalK [26] and BtuCD indicate
[27] that ATP binding induces NBD dimerization via a tweezers-like
motion. The high sequence homology across all ABC transporter
NBDs and the recent publication of several ABC transporters crystal-
lized in the open [28], semi-open [22] and closed states [11,23] suggests
this is a general mechanism, thus a similar change is likely in P-gp. We
used the nucleotide-free MalK semi-open (1Q1B.pdb) and open
(1Q1E.pdb) structures as templates to investigate possible conforma-
tions of P-gp in the nucleotide-free state. The modelled P-gp ICLs
(Fig. 2) protrude deep into the adjoining NBD, suggesting an ICL–
NBD coupling mechanism. The NBD–ICL contact regions are the
tether points for the TMD–ICL motion induced by NBD conforma-
tional change [11]. As such, we expect the overall conformation of
the NBD–ICL contact points to change very little during nucleotide
dissociation, thus they are used as the starting conﬁguration to model
TMD–ICL conformational changes. While the NBDs provide the driv-
ing force for the conformational changes that facilitate substrate trans-
port, the geometrical constraints of the TM wings dictate the
conformational changes occurring in the TMD–ICL must be more
pronounced in regions adjacent to the NBDs.
To mimic a nucleotide-free NBD conformation, each half of the P-
gp model was cleaved above the ICLs, producing NBD–ICL models
for each P-gp half transporter. A TMD–ICL model for the full trans-
porter was also made. To develop a P-gp homology model correspond-
ing to the MalK semi-open state, the coordinates of the NBD–ICL
models are superimposed on the corresponding NBD of the semi-open
MalK structure (Fig. 2a). The TMD–ICL model is overlaid on the
transformed NBD–ICL models, maintaining its original orientation.
The TMD–ICL model is considered as sets of helix–loop–helix motifs,
where TM helices are connected by the adjoining ICL and small angle
rotations of each helix–loop–helix are applied so that the NBD contact
point of each TMD–ICL loop ﬁts that of the NBD–ICL model
(Fig. 2b). The ICL guides from the NBD–ICL models are removed
and the reoriented TMD–ICL models are ligated to the NBDs. The
model is reﬁned to reﬂect any conformational changes prior to energy
minimization, giving a projected conformation of P-gp in the NBD
semi-open state (Fig. 2c). Using this P-gp semi-open homology model
and MalK open state crystal structure as an initial conﬁguration, the
same procedure is followed to deduce an open state NBD conforma-
tion. The quality of the semi-open and open state P-gp models, veriﬁed
using WHATIF [20], are comparable to that of Sav1866. The Rama-
chandran plot showed 98% residues in favorable regions for both the
semi-open and open state models, indicating no signiﬁcant deforma-
tions of the backbone geometry occurred in the state transition. Sepa-
ration of the Walker A cysteine residues is 31.9 A˚ for the semi-open
and 34.2 A˚ for the open state models, in agreement with the FRET
estimate of 30 A˚ [24].3. Results
3.1. Closed state P-gp homology model
Our closed state P-gp homology model (Fig. 1) is conform-
ationally distinct and more extensive than previous MsbA-
based models, mapping over 90% of the sequence. The
arrangement of the closed state TMDs (Fig. 3) shows marked
pseudo-symmetry, consistent with the 8 A˚ EM structure [10].
The modelled TM1 is elongated, extending past the extracellu-
lar membrane by approximately 4 a-helical turns, concurring
with an elongated helix in TMD1 seen in the EM structure
[10]. The hydrophobic belt is assessed by embedding the model
in a POPE bilayer and allowing the lipids to equilibrate around
it (Fig. 4). The vast majority of the surface accessible charged
and polar residues (blue) lie outside the bilayer. The lipid-
embedded TMDs contain a relatively large proportion of
hydrophilic residues, although very few are lipid accessible.
These lipid accessible hydrophilic residues are predominantly
located at the interface of TM helices, particularly between
the TM wings. The majority of hydrophilic residues in the
Fig. 2. To develop a semi-open P-gp conformation, (a) the NBD–ICL models were superimposed on MalK 1Q1B.pdp (purple). (b) The ICL guides
(transparent) are the key regions for reorienting the TMD–ICL model before reﬁnement to give (c) the semi-open conformation. Transformation to
the semi-open state involves distal rotation of the NBDs (c), which is transferred to the ICLs (1&4 blue; 2&5 red; 3&6 orange) as lateral and
rotational motion, widening the translocation pore.
Fig. 3. Superimposed homology models of P-gp representing three possible stages of the catalytic cycle: (a) and (d) the nucleotide-bound closed state;
(b) and (e) semi-open state; (c) and (f) nucleotide-free open state. The TM helices are color coded: TM1&7 blue; TM2&8 red; TM3&9 orange;
TM4&10 yellow; TM5&11 green; TM6&12 purple.
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tent with analysis of the Sav1866 structures, which show thetranslocation pore is remarkably polar, suggesting the ATP-
bound conformation represents an extrusion pore [11].
Fig. 4. Solvent accessible surface of the (a) closed, (b) semi-open and (c) open state P-gp models, viewed to maximize the opening between the TMD
wings (TMD1 on the left). Hydrophilic residues (blue) are predominantly situated outside the lipid bilayer, the head groups of which are shown as
spaceﬁll atoms. Non-polar residues are shown in grey. The hydrophobic belt of the semi-open and open state models contains a slight tilt.
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a-carbons) between our three P-gp model TM helices and the
experimentally cross-linked residues. The majority of the mod-
elled inter-residue distances and experimental results correlate,
indicating the P-gp model represents a feasible starting confor-
mation. In particular, residue pairs on TM1 and 11, TM2 and
11, TM5 and 12 and TM5 and 8 correlate well in distance esti-
mates.
Site directed labelling studies show TM6 is the lynch-pin in
NBD1 and TMD1 coupling, undergoing signiﬁcant reorienta-
tion throughout the nucleotide catalytic cycle and tilting on
ATP release [29]. These ﬁndings correspond to the three puta-
tive P-gp conformations modelled here, where there is signiﬁ-
cant change in both TM6 and TM12 orientation between the
three models, particularly the closed and open state conﬁgura-
tions. Experimental studies have demonstrated that Leu339 in
TM6 is crucial in inter-domain communication [30]. The mod-
elled TM6 contains a signiﬁcant bend in the region of the
extracellular lipid–water interface around Leu339, where the
normal a-helical hydrogen bonding pattern is disrupted. The
region from T333 to I340 is mainly adjacent b-branched and
aromatic amino acids, which destabilize the a-helix through
energetically unfavorable packing combinations, like the i,
i + 2 combination of b-branched residues [31]. Here the posi-
tioning of a bulky leucine (L339) between two b-branched res-
idues gives a characteristic but generally uncommon valine–
leucine–isoleucine (VLI) motif which creates an extended ridge
in native proteins [32]. This distortion of the modelled TM6 in-
creases the surface accessibility of Leu339, consistent with
experimental results [30]. Recent investigations have shown
Gly346, located intracellularly to Leu339, is a key residue in
ATP hydrolysis [33]. The corresponding in silico G346C muta-
tion shows the cysteine side chain is coordinated by residues
from TM5, stabilizing inter-helix interactions. This could
potentially decrease the mobility of TM6, which in turn, may
aﬀect the rate of ATP hydrolysis. A pseudo-symmetrical
arrangement in TM12 shows a deformation in the correspond-ing helical position (A980–M986), where the a-helical bonding
is disrupted by three consecutive b-branched and aromatic res-
idues, V981, V982 and F983. In the modelled TM12, Val982 is
the most solvent-accessible residue in the TM12 deformation.
3.2. Apo P-gp homology models: the semi-open and open states
Experiments [25] and simulations [26] on the MalK NBDs
indicate ATP binding induces NBD dimerization via a twee-
zers-like motion, which is reversed on nucleotide release. The
conformational similarities and high sequence conservation
in the NBDs suggest a similar motion occurs in P-gp on
ATP binding. EM images and antibody labelling of P-gp at
diﬀerent stages of the catalytic cycle show P-gp adopts distinct
nucleotide-free or nucleotide-bound conformations [34,35].
The predicted change in the NBD orientation is characterized
by a pincering rotational motion of each NBD, producing an
inwards pivot of the NBDs, which forces the ICLs laterally
outwards (Fig. 2).
A comparison of the closed state and semi-open P-gp models
shows that the initial stage of NBD decoupling induces coun-
ter-clockwise rotations of the TMDs and ICLs (Fig. 3). This
anti-clockwise rotation is the predominant motion in the
TMDs and ICLs, widening the intracellular aspect of the sub-
strate translocation pore. NBD decoupling also induces a
small secondary lateral motion in the TMD–ICLs. The overall
RMSD between the nucleotide-bound P-gp model and the
semi-open model is 5.25 A˚. Comparison of the semi-open to
the open state P-gp model (Fig. 3) shows the outwards pincer-
ing of the NBDs is transformed into a predominantly lateral
outwards motion in the TMD–ICL during NBD dissociation,
with a small anti-clockwise rotational component. The out-
wards lateral motion produces a marked widening of the intra-
cellular and membrane-embedded regions of the pore, opening
conduits between TM4&6, and also TM10&12, allowing access
to the translocation pore. The rotational and translational
components of the TMD–ICL motion, together with the
NBD motion, correspond to the two lowest frequency normal
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all three P-gp models and the ADP-bound Sav1866 structure
[36]. In practice, neither mode is present in isolation, but rep-
resents a dominant mode in a particular state translation in the
catalytic cycle. The RMSD between the semi-open P-gp model
and the open state model is 8.67 A˚, while the RMSD between
the nucleotide-bound and open state models is 12.52 A˚.4. Discussion
In the absence of high-resolution structures, homology mod-
els provide a three-dimensional map of a protein. As structural
predictions, they require progressive reﬁnement when new re-
sults become available. The crucial factors determining the
quality of a homology model are the accuracy of the sequence
alignment and the quality and resolution of the template struc-
ture. The scarcity of suitable template structures is currently a
critical limitation. Here, the entire sequence of Sav1866 has
been resolved to 3.0 A˚, increasing conﬁdence in the quality
of the crystal structure. The sequence identity varies markedly
across the protein. NBD1 and NBD2 have 44% and 48% se-
quence identity, respectively, providing a strong basis for accu-
rate homology modelling. The sequence identity is <20% in the
TMDs, far below the critical limit for globular proteins. How-
ever, the TMD alignments displays a number of partially con-
served residue clusters, giving 56% and 52.8% sequence
similarity in TMD1 and TMD2, providing suﬃcient correla-
tion for reliable homology modelling of a constrained integral
membrane protein. Additional PSI-BLAST [13] searches for
Sav1866 and human P-gp showed an E value of 5 · 1072, indi-
cating an extremely high probability that P-gp and Sav1866
share the same architecture. This is supported by recent exper-
iments demonstrating that ICL4 of P-gp interacts with NBD2,
in a Sav1866-like domain interlinking pattern [12]. These con-
clusions have led us to believe that the closed state P-gp model
is as accurate as the current methods allow.
The conformational changes leading to the semi-open and
open P-gp models are supported by spin-labeling and electron
paramagnetic resonance studies on the bacterial homologue
MsbA, which indicate rigid-body motions, accompanied by a
hinging of TM6, open the translocation pore in the absence
of nucleotides [37]. The projected TMD conformational
changes in the semi-open and open state models alter both
the shape and residue distribution of the translocation pore.
In the closed state P-gp, the translocation pore is lined with po-
lar residues, consistent with the hydrophilic Sav1866 pore [11].
Residues from TM3, 4, 6, 9, 10 and 12 form a hydrophilic iris
in the region of the intracellular bilayer leaﬂet. The semi-open
state is characterized by a dilation of the iris and a rotation of
TM4, 6, 10 and 12, exposing hydrophobic residues to the mem-
brane-embedded translocation pore. This trend continues in
the open state model, where the majority of hydrophilic resi-
dues are shifted to inter-helical regions, while a few are clus-
tered in lipid exposed crevasses on the surface of the apo
models (Fig. 4). The extracellular aspect of the TMDs is still
physically open at the lipid–water interface, although clusters
of hydrophilic residues line the pore and between the diverging
TMD wings. This combination of factors suggests that apo
states in the native P-gp may have a denser TMD packing than
the open state, and to a lesser extent, the semi-open state mod-
els.The cross-linking data presented in Table S2 has been col-
lected under a range of conditions, in the presence and absence
of drug substrates and chemical cross-linkers. In general, the
inter-residue distances from all three models correlate well with
the studies where cross-linking reagents have been used. Com-
parative inter-residue distances tend to diverge more in studies
probing the translocation pore with reducing agents. Of the
three P-gp models, the closed state model performs slightly
better than the other two models and thus, is considered the
most reliable, followed by the semi-open state, although the
diﬀerence in residue pair distances between the three models
is less than 10 A˚.
The recent publication of Sav1866 [11] and the subsequent
withdrawal of the three MsbA structures [8], on which all pre-
vious P-gp models were based, requires the reinterpretation of
many pieces of data [9]. The semi-open and open state P-gp
homology models we developed were created from the MalK
NBD motion derived from crystallographic information. They
represent two predicted structures developed from homology
modelling with subsequent energy minimization and reﬁne-
ment. To date, ﬁve MalK crystal structures have been pub-
lished. Three have been considered in this study. The two
remaining structures are MgADP bound. One of these closely
resembles the semi-open state and the other resembles the open
state [38], indicating a signiﬁcant ﬂexibility in the NBDs in the
absence of ATP. As P-pg must go through the ADP-bound
state to reset the NBDs for the next catalytic cycle [38], the
ﬂexibility of the ADP-bound states in MalK suggests our mod-
els may represent three stages of the catalytic cycle: an ATP-
bound closed state, an ADP-bound (or nucleotide free) semi-
open state, and an open state nucleotide free or ADP-bound
conformation (Fig. 3). Determining the probable conforma-
tional changes allowed us to characterize possible conforma-
tions throughout the catalytic cycle and describe how
nucleotide binding is communicated to the TMDs. We hope
this additional information, when combined with experimental
studies, can shed insights into the structural changes facilitat-
ing substrate transport.
Acknowledgments: This research was funded by the Canadian Insti-
tutes of Health Research. M.L.O. is a CIHR postdoctoral fellow.
D.P.T. is an Alberta Heritage Foundation for Medical Research Se-
nior Scholar and a CIHR New Investigator. We thank Eliud Oloo,
Richard Callaghan, Ian Kerr and Peter Chiba for their insights and
discussions; and Peter Chiba for the use of his sequence alignment.
Thanks also to Richard Callaghan and Ian Kerr for critically reading
our manuscript.Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febs-
let.2007.07.069.
References
[1] Ecker, G., Huber, M., Schmid, D. and Chiba, P. (1999) The
importance of a nitrogen atom in modulators of multidrug
resistance. Mol. Pharmacol. 56, 791–796.
[2] Seelig, A. (1998) A general pattern for substrate recognition by P-
glycoprotein. Eur. J. Biochem. 251, 252–261.
[3] Ambudkar, S.V., Kimchi-Sarfaty, C., Sauna, Z.E. and Gottes-
man, M.M. (2003) P-glycoprotein: from genomics to mechanism.
Oncogene 22, 7468–7485.
4222 M.L. O’Mara, D.P. Tieleman / FEBS Letters 581 (2007) 4217–4222[4] Kim, R.B., Fromm, M.F., Wandel, C., Leake, B., Wood, A.J.,
Roden, D.M. and Wilkinson, G.R. (1998) The drug transporter
P-glycoprotein limits oral absorption and brain entry of HIV-1
protease inhibitors. J. Clin. Invest. 101, 289–294.
[5] Lee, C.G., Gottesman, M.M., Cardarelli, C.O., Ramachandra,
M., Jeang, K.T., Ambudkar, S.V., Pastan, I. and Dey, S. (1998)
HIV-1 protease inhibitors are substrates for the MDR1 multidrug
transporter. Biochemistry 37, 3594–3601.
[6] Gottesman, M.M. and Ling, V. (2006) The molecular basis of
multidrug resistance in cancer: the early years of P-glycoprotein
research. FEBS Lett. 580, 998–1009.
[7] Borst, P. and Oude-Elferink, R. (2002) Mammalian ABC trans-
porters in health and disease. Annu. Rev. Biochem. 71, 537–592.
[8] Chang, G., Roth, C.B., Reyes, C.L., Pronillos, O., Chen, Y.-J.
and Chen, A.P. (2006) Retraction. Science 314, 1875.
[9] Miller, G. (2006) A Scientist’s nightmare: software problem leads
to ﬁve retractions. Science 314, 1856–1857.
[10] Rosenberg, M.F., Callaghan, R., Modok, S., Higgins, C.F. and
Ford, R.C. (2005) Three-dimensional structure of P-glycoprotein:
the transmembrane regions adopt an asymmetric conﬁguration in
the nucleotide-bound state. J. Biol. Chem. 280, 2857–2862.
[11] Dawson, R.J.P. and Locher, K.P. (2006) Structure of a bacterial
multidrug ABC transporter. Nature 443, 180–185.
[12] Zolnerciks, J.K., Wooding, C. and Linton, K.J. (2007) Evidence
for a Sav1866-like architecture for the human multidrug trans-
porter P-glycoprotein. FASEB J., doi:10.1096/fj.07-8610com.
[13] Altschul, S.F., Madden, T.L., Scha¨ﬀer, A.A., Zhang, J., Zhang,
Z., Miller, W. and Lipman, D.J. (1997) Gapped BLAST and PSI-
BLAST: a new generation of protein database search programs.
Nucleic Acids Res. 25, 3389–3402.
[14] Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) CLUS-
TAL W: improving the sensitivity of progressive multiple
sequence alignment through sequence weighting, position-speciﬁc
gap penalties and weight matrix choice. Nucleic Acids Res. 22,
4673–4680.
[15] Rost, B., Yachdav, G. and Liu, J. (2003) The PredictProtein
Server. Nucleic Acids Res. 32, W321–W326.
[16] Schwede, T., Kopp, J., Guex, N. and Peitsch, M.C. (2003)
SWISS-MODEL: an automated protein homology-modeling
server. Nucleic Acids Res. 31, 3381–3385.
[17] Guex, N. and Peitsch, M.C. (1997) SWISS-MODEL and the
Swiss-PdbViewer: an environment for comparative protein mod-
elling. Electrophoresis 18, 2714–2723.
[18] Kandt, C., Ash, W. and Tieleman, D. (2007) Setting up and
running molecular dynamics simulations of membrane proteins.
Methods 41, 475–488.
[19] Fan, H. and Mark, A.E. (2004) Reﬁnement of homology-based
protein structures by molecular dynamics simulation techniques.
Protein Sci. 2004, 211–220.
[20] Vriend, G. (1990) WHAT IF: a molecular modelling and drug
design program. J. Mol. Graph. 8, 52–56.
[21] Laskowski, R.A., MacArthur, M.W., Moss, D.S. and Thornton,
J.M. (1993) PROCHECK: a program to check the stereochemical
quality of protein structures. J Appl. Cryst. 26, 283–291.
[22] Pinkett, H.P., Lee, A.T., Lum, P., Locher, K.P. and Rees, D.C.
(2007) An inward-facing conformation of a putative metal-
chelate-type ABC transporter. Science 315, 373–377.
[23] Dawson, R.J.P. and Locher, K.P. (2007) Structure of the
multidrug ABC transporter Sav1866 from Staphylococcus aureus
in complex with AMP-PNP. FEBS Lett. 581, 935–938.[24] Qu, Q. and Sharom, F.J. (2001) FRET analysis indicates that the
two ATPase active sites of the P-glycoprotein multidrug trans-
porter are closely associated. Biochemistry 40, 1413–1422.
[25] Chen, J., Lu, G., Lin, J., Davidson, A.L. and Quiocho, F.A.
(2003) A tweezers-like motion of the ATP-binding cassette dimer
in an ABC transport cycle. Mol. Cell 12, 651–661.
[26] Oloo, E.O., Fung, E.Y. and Tieleman, D.P. (2006) The dynamics
of the MgATP-driven closure of MalK, the energy-transducing
subunit of the maltose ABC transporter. J. Biol. Chem.,
doi:10.1074/jbc.M513614200.
[27] Oloo, E.O. and Tieleman, D.P. (2004) Conformational transitions
induced by the binding of MgATP to the Vitamin B12 ATP-
binding Cassette (ABC) transporter BtuCD. J. Biol. Chem. 43,
45013–45019.
[28] Hollenstein, K., Frei, D.C. and Locher, K.P. (2007) Structure of
an ABC transporter in complex with its binding protein. Nature
446, 213–216.
[29] Rothnie, A., Storm, J., Campbell, J., Linton, K.J., Kerr, I.D. and
Callaghan, R. (2004) The topography of transmembrane segment
six is altered during the catalytic cycle of P-glycoprotein. J Biol.
Chem. 279, 34913–34921.
[30] Rothnie, A., Storm, J., McMahon, R., Taylor, A., Kerr, I.D. and
Callaghan, R. (2005) The coupling mechanism of P-glycoprotein
involves residue L339 in the sixth membrane spanning segment.
FEBS Lett. 597, 3984–3990.
[31] Senes, A., Gerstein, M. and Engelman, D.M. (2000) Statistical
analysis of amino acid patterns in transmembrane helices: the
GxxxG motif occurs frequently and in association with b-
branched residues at neighboring positions. J. Mol. Biol. 296,
919–934.
[32] Russ, W.P. and Engelman, D.M. (2000) The GxxxG motif: a
framework for transmembrane helix–helix association. J. Mol.
Biol. 296, 911–919.
[33] Storm, J., O’Mara, M.L., Crowley, E., Peall, J., Tieleman, D.P.,
Kerr, I.D. and Callaghan, D. (2007) Residue G346C in the
transmembrane segment six is involved in inter-domain commu-
nication in P-glycoprotein. Biochemistry, in press.
[34] Rosenberg, M.F., Kamis, A.B., Callaghan, R., Higgins, C.F. and
Ford, R.C. (2003) Three-dimensional structures of the mamma-
lian multidrug resistance P-glycoprotein demonstrate major
conformational changes in the transmembrane domains upon
nucleotide binding. J. Biol. Chem. 278, 8294–8299.
[35] Rosenberg, M.F., Velarde, G., Ford, R.C., Martin, C., Berridge,
G., Kerr, I.D., Callaghan, R., Schmidlin, A., Wooding, C.,
Linton, K.J. and Higgins, C.F. (2001) Repacking of the trans-
membrane domains of P-glycoprotein during the transport
ATPase cycle. EMBO J. 20, 5615–5625.
[36] Lindahl, E., Azuara, C., Koehl, P. and Delarue, M. (2006)
NOMAD-Ref: visualization, deformation and reﬁnement of
macromolecular structures based on all-atom normal mode
analysis. Nucleic Acids Res. 34, W52–W56.
[37] Dong, J., Yang, G. and Mchaourab, H.S. (2005) Structural basis
of energy transduction in the transport cycle of MsbA. Science
308, 1023–1028.
[38] Lu, G., Westbrooks, J.M., Davidson, A.L. and Chen, J. (2005)
ATP hydrolysis is required to reset the ATP-binding cassette
dimer into the resting-state conformation. PNAS 102, 17969–
17974.
